Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006

Emerging Infectious Diseases

Volumn 17, Issue 10, 2011, Pages 1855-1864

  Park, Benjamin J ^a   Pappas, Peter G ^b   Wannemuehler, Kathleen A ^a   Alexander, Barbara D ^c   Anaissie, Elias J ^d   Andes, David R ^e   Baddley, John W ^b   Brown, Janice M ^f   Brumble, Lisa M ^g   Freifeld, Alison G ^h   Hadley, Susan ⁱ   Herwaldt, Loreen ^j   Ito, James I ^k   Kauffman, Carol A ^l,m   Lyon, G Marshall ⁿ   Marr, Kieren A ^o,p   Morrison, Vicki A ^q,r   Papanicolaou, Genovefa ^s   Patterson, Thomas F ^t,u   Perl, Trish M ^o   Schuster, Mindy G ^v   Walker, Randall ^w   Wingard, John R ^x   Walsh, Thomas J ^y   Kontoyiannis, Dimitrios P ^z   more..

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MAYO CLINIC   (United States)

^h UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

ⁱ TUFTS MEDICAL CENTER   (United States)

^j UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^k CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^l UNIVERSITY OF MICHIGAN   (United States)

^m Veteran's Affairs Ann Arbor Healthcare System   (United States)

ⁿ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o DEPARTMENT OF PATHOLOGY   (United States)

^p Fred Hutchinson Cancer Research Center   (United States)

^q UNIVERSITY OF MINNESOTA   (United States)

^r VA MEDICAL CENTER   (United States)

^s MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^t UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^u SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^v HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^w MAYO CLINIC   (United States)

^x UNIVERSITY OF FLORIDA   (United States)

^y NATIONAL INSTITUTES OF HEALTH   (United States)

^z UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

ABSIDIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APOPHYSOMYCES; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CUNNINGHAMELLA; DISEASE SURVEILLANCE; FEMALE; FUSARIOSIS; FUSARIUM; FUSARIUM MONILIFORME; FUSARIUM OXYSPORUM; FUSARIUM PROLIFERATUM; FUSARIUM SOLANI; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUCOR; MUCORALES; MUCORMYCOSIS; PSEUDALLESCHERIASIS; RHIZOMUCOR; RHIZOPUS; SCEDOSPORIUM; SCEDOSPORIUM APIOSPERMUM; SCEDOSPORIUM PROLIFICANS; SYNCEPHALASTRUM; SYSTEMIC MYCOSIS; UNITED STATES;

EID: 84930472422     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1710.110087     Document Type: Article

References (35)

1. Husain S, Alexander BD, Munoz P, Avery RK, Houston S, Pruett T, et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis. 2003;37:221-9. doi:10.1086/375822
2. Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases [see comment]. J Infect Dis.2005;191:1350-60. doi:10.1086/428780
3. Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants [comment]. N Engl J Med. 2004;350:950-2. doi:10.1056/NEJM200402263500923
4. Trifllio SM, Bennett CL, Yarnold PR, McKoy JM, Parada J, Mehta J, et al. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant. 2007;39:425-9. doi:10.1038/sj.bmt.1705614
5. Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) database. Clin Infect Dis. 2010;50:1091-100. doi:10.1086/651263
6. Morgan J, Wannemuehler KA, Marr KA, Hadley S, Kontoyiannis DP, Walsh TJ, et al. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplant: interim results of a prospective multicenter surveillance program. Med Mycol.2005;43(Suppl 1):S49-58. doi:10.1080/13693780400020113
7. Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010;50:1101-11. doi:10.1086/651262
8. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. Deflning opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34:7-14. doi:10.1086/323335
9. Singh N, Aguado JM, Bonatti H, Forrest G, Gupta KL, Safdar N, et al. Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis. 2009;200:1002-11. doi:10.1086/605445
10. Sun HY, Forrest G, Gupta KL, Aguado JM, Lortholary O, Julia MB, et al. Rhino-orbital-cerebral zygomycosis in solid organ transplant recipients. Transplantation. 2010;90:85-92. doi:10.1097/TP.0b013e3181dde8fc
11. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634-53. doi:10.1086/432579
12. Bethge WA, Schmalzing M, Stuhler G, Schumacher U, Kröber SM, Horger M, et al. Mucormycoses in patients with hematologic malignancies: an emerging fungal infection. Haematologica.2005;90(Suppl):ECR22.
13. Chamilos G, Luna M, Lewis RE, Bodey GP, Chemaly R, Tarrand JJ, et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica. 2006;91:986-9.
14. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002;34:909-17. doi:10.1086/339202
15. Garcia-Vidal C, Upton A, Kirby KA, Marr KA. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin Infect Dis. 2008;47:1041-50. doi:10.1086/591969
16. Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis. 2009;48:265-73. doi:10.1086/595846
17. Pagano L, Valentini CG, Posteraro B, Girmenia C, Ossi C, Pan A, et al. Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology). J Chemother. 2009;21:322-9.
18. Bitar D, Van Cauteren D, Lanternier F, Dannaoui E, Che D, Dromer F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006. Emerg Infect Dis. 2009;15:1395-401. doi:10.3201/eid1509.090334
19. Lionakis MS, Kontoyiannis DP. Sinus zygomycosis in a patient receiving voriconazole prophylaxis. Br J Haematol. 2005;129:2. doi:10.1111/j.1365-2141.2005.05384.x
20. Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis. 2004;39:743-6. doi:10.1086/423274
21. Siwek GT, Dodgson KJ, de Magalhaes-Silverman M, Bartelt LA, Kilborn SB, Hoth PL, et al. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis. 2004;39:584-7. doi:10.1086/422723
22. Lamaris GA, Ben-Ami R, Lewis RE, Chamilos G, Samonis G, Kontoyiannis DP. Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis. J Infect Dis. 2009;199:1399-406. doi:10.1086/597615
23. Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis.2000;30:851-6. doi:10.1086/313803
24. Wingard JR, Carter SL, Walsh TJ, Kurtzberg J, Small TN, Baden LR, et al. Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. Blood. 2010;116:5111-8.
25. Pongas GN, Lewis RE, Samonis G, Kontoyiannis DP. Voriconazoleassociated zygomycosis: a signiflcant consequence of evolving antifungal prophylaxis and immunosuppression practices? Clin Microbiol Infect. 2009;15(Suppl 5):93-7. doi:10.1111/j.1469-0691.2009.02988.x
26. Panackal AA, Li H, Kontoyiannis DP, Mori M, Perego CA, Boeckh M, et al. Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation. Clin Infect Dis. 2010;50:1588-97.doi:10.1086/652761
27. Kontoyiannis DP, Chamilos G, Hassan SA, Lewis RE, Albert ND, Tarrand JJ. Increased culture recovery of Zygomycetes under physiologic temperature conditions. Am J Clin Pathol. 2007;127:208-12. doi:10.1309/7KU5XWURYM0151YN
28. Chang DC, Burwell LA, Lyon GM, Pappas PG, Chiller TM, Wannemuehler KA, et al. Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis. Infect Control Hosp Epidemiol. 2008;29:25-30. doi:10.1086/524324
29. Campo M, Lewis RE, Kontoyiannis DP. Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009. J Infect. 2010;60:331-7. doi:10.1016/j.jinf.2010.01.010
30. Boutati EI, Anaissie EJ. Fusarium, a signiflcant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood.1997;90:999-1008.
31. Lamaris GA, Chamilos G, Lewis RE, Safdar A, Raad II, Kontoyiannis DP. Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006. Clin Infect Dis. 2006;43:1580-4. doi:10.1086/509579
32. Husain S, Munoz P, Forrest G, Alexander BD, Somani J, Brennan K, et al. Infections due to Scedosporium apiospermum and Scedosporium proliflcans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis.2005;40:89-99. doi:10.1086/426445
33. Idigoras P, Perez-Trallero E, Pineiro L, Larruskain J, López-Lopategui MC, Rodríguez N, et al. Disseminated infection and colonization by Scedosporium proliflcans: a review of 18 cases, 1990-1999. Clin Infect Dis. 2001;32:E158-65. doi:10.1086/320521
34. Balajee SA, Sigler L, Brandt ME. DNA and the classical way: identiflcation of medically important molds in the 21st century. Med Mycol.2007;45:475-90. doi:10.1080/13693780701449425
35. Muñoz-Cadavid C, Rudd S, Zaki SR, Patel M, Moser SA, Brandt ME, et al. Improving molecular detection of fungal DNA in formalin- flxed paraffln-embedded tissues: comparison of flve tissue DNA extraction methods using panfungal PCR. J Clin Microbiol.2010;48:2147-53. doi:10.1128/JCM.00459-10